A survival analysis of surgically treated incidental low-grade glioma patients

Abstract To evaluate the surgical effect on survival in patients with incidental low-grade glioma (LGG) through comparison between asymptomatic and symptomatic patients. The medical records of surgically treated adult cerebral incidental LGG (iLGG) patients in our department between January 2008 and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lingcheng Zeng, Qi Mei, Hua Li, Changshu Ke, Jiasheng Yu, Jian Chen
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5d932271a0674da8adf47625cd56fc04
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5d932271a0674da8adf47625cd56fc04
record_format dspace
spelling oai:doaj.org-article:5d932271a0674da8adf47625cd56fc042021-12-02T16:45:39ZA survival analysis of surgically treated incidental low-grade glioma patients10.1038/s41598-021-88023-y2045-2322https://doaj.org/article/5d932271a0674da8adf47625cd56fc042021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-88023-yhttps://doaj.org/toc/2045-2322Abstract To evaluate the surgical effect on survival in patients with incidental low-grade glioma (LGG) through comparison between asymptomatic and symptomatic patients. The medical records of surgically treated adult cerebral incidental LGG (iLGG) patients in our department between January 2008 and December 2015 were retrospectively reviewed. The survival of patients was calculated starting from the initial imaging diagnosis. Factors related to progression-free survival (PFS), overall survival (OS) and malignant progression-free survival (MPFS) were statistically analyzed. Seventy-five iLGG patients underwent surgery: 49 in the asymptomatic group, who underwent surgery in the asymptomatic period, and 26 in the symptomatic group, who underwent surgery after the tumor had grown and the patients had developed tumor-related symptoms. Significantly more tumors were initially located adjacent to the functional area in the symptomatic group than in the asymptomatic group (P < 0.05), but there was no significant difference in the total resection rate between the two groups. The incidence of postoperative complications (15.4%) and postoperative epilepsy (23.1%) was higher in the symptomatic group than in the asymptomatic group (4.1% and 10.2%, respectively). Multivariate analysis showed that surgical timing, namely, surgery performed before or after symptom occurrence, had no significant effect on PFS, OS or MPFS, while total resection significantly prolonged PFS, OS and MPFS, and the pathology of oligodendroglioma was positively correlated with PFS and OS (P < 0.05). Surgical timing for iLGGs should facilitate total resection. If total resection can be achieved, even after symptom occurrence, patients can achieve comparable survival benefits to those treated with surgery in the asymptomatic phase.Lingcheng ZengQi MeiHua LiChangshu KeJiasheng YuJian ChenNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Lingcheng Zeng
Qi Mei
Hua Li
Changshu Ke
Jiasheng Yu
Jian Chen
A survival analysis of surgically treated incidental low-grade glioma patients
description Abstract To evaluate the surgical effect on survival in patients with incidental low-grade glioma (LGG) through comparison between asymptomatic and symptomatic patients. The medical records of surgically treated adult cerebral incidental LGG (iLGG) patients in our department between January 2008 and December 2015 were retrospectively reviewed. The survival of patients was calculated starting from the initial imaging diagnosis. Factors related to progression-free survival (PFS), overall survival (OS) and malignant progression-free survival (MPFS) were statistically analyzed. Seventy-five iLGG patients underwent surgery: 49 in the asymptomatic group, who underwent surgery in the asymptomatic period, and 26 in the symptomatic group, who underwent surgery after the tumor had grown and the patients had developed tumor-related symptoms. Significantly more tumors were initially located adjacent to the functional area in the symptomatic group than in the asymptomatic group (P < 0.05), but there was no significant difference in the total resection rate between the two groups. The incidence of postoperative complications (15.4%) and postoperative epilepsy (23.1%) was higher in the symptomatic group than in the asymptomatic group (4.1% and 10.2%, respectively). Multivariate analysis showed that surgical timing, namely, surgery performed before or after symptom occurrence, had no significant effect on PFS, OS or MPFS, while total resection significantly prolonged PFS, OS and MPFS, and the pathology of oligodendroglioma was positively correlated with PFS and OS (P < 0.05). Surgical timing for iLGGs should facilitate total resection. If total resection can be achieved, even after symptom occurrence, patients can achieve comparable survival benefits to those treated with surgery in the asymptomatic phase.
format article
author Lingcheng Zeng
Qi Mei
Hua Li
Changshu Ke
Jiasheng Yu
Jian Chen
author_facet Lingcheng Zeng
Qi Mei
Hua Li
Changshu Ke
Jiasheng Yu
Jian Chen
author_sort Lingcheng Zeng
title A survival analysis of surgically treated incidental low-grade glioma patients
title_short A survival analysis of surgically treated incidental low-grade glioma patients
title_full A survival analysis of surgically treated incidental low-grade glioma patients
title_fullStr A survival analysis of surgically treated incidental low-grade glioma patients
title_full_unstemmed A survival analysis of surgically treated incidental low-grade glioma patients
title_sort survival analysis of surgically treated incidental low-grade glioma patients
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/5d932271a0674da8adf47625cd56fc04
work_keys_str_mv AT lingchengzeng asurvivalanalysisofsurgicallytreatedincidentallowgradegliomapatients
AT qimei asurvivalanalysisofsurgicallytreatedincidentallowgradegliomapatients
AT huali asurvivalanalysisofsurgicallytreatedincidentallowgradegliomapatients
AT changshuke asurvivalanalysisofsurgicallytreatedincidentallowgradegliomapatients
AT jiashengyu asurvivalanalysisofsurgicallytreatedincidentallowgradegliomapatients
AT jianchen asurvivalanalysisofsurgicallytreatedincidentallowgradegliomapatients
AT lingchengzeng survivalanalysisofsurgicallytreatedincidentallowgradegliomapatients
AT qimei survivalanalysisofsurgicallytreatedincidentallowgradegliomapatients
AT huali survivalanalysisofsurgicallytreatedincidentallowgradegliomapatients
AT changshuke survivalanalysisofsurgicallytreatedincidentallowgradegliomapatients
AT jiashengyu survivalanalysisofsurgicallytreatedincidentallowgradegliomapatients
AT jianchen survivalanalysisofsurgicallytreatedincidentallowgradegliomapatients
_version_ 1718383454972805120